# A Open-label Study of Ultra-High Dose Dexamethasone for Relapsed Multiple Myeloma

> **NCT02402725** · PHASE2 · WITHDRAWN · sponsor: **Boston Medical Center**

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT02402725
- **Lead sponsor:** Boston Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-05
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** poor accrual
- **Last updated:** 2017-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02402725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02402725, "A Open-label Study of Ultra-High Dose Dexamethasone for Relapsed Multiple Myeloma". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT02402725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*